HomeNASDAQ:BIIB

NASDAQ:BIIB

Reasons Why Biogen Stock Jumps Almost 5% on Tuesday

Reasons Why Biogen Stock Jumps Almost 5% on Tuesday

April 25, 2024

Biogen Decides to Halt Aduhelm, Shifting Focus to Alternative Alzheimer’s Treatments

Biogen Decides to Halt Aduhelm, Shifting Focus to Alternative Alzheimer’s Treatments

January 31, 2024

Biogen Reduces Profit Forecast Due to Alzheimer’s Drug Launch Costs and M&A, Shares Decline

Biogen Reduces Profit Forecast Due to Alzheimer’s Drug Launch Costs and M&A, Shares Decline

November 8, 2023

Biogen Stock Fell Because It Thinks a New Alzheimer’s Drug Will Hurt Its 2023 Outlook

Biogen Stock Fell Because It Thinks a New Alzheimer’s Drug Will Hurt Its 2023 Outlook

February 15, 2023

Analysts Believe That Biogen Stock Fell Due to the Rapid Approval of Lecanemab

Analysts Believe That Biogen Stock Fell Due to the Rapid Approval of Lecanemab

January 5, 2023